Exhibit 10.1
TERMINATION AND REPURCHASE AGREEMENT
This Termination and Repurchase
Agreement, effective as of June 11, 2007, is entered into by
and between Aspect Medical Systems, Inc., a Delaware corporation
having a principal place of business at One Upland Road, Norwood,
Massachusetts 02062 (“AMS”), and Boston Scientific
Corporation, a Delaware corporation having a principal place of
business at One Boston Scientific Place, Natick, Massachusetts
01760 (“BSC”).
WHEREAS, AMS and BSC entered into
that certain OEM Product Development Agreement as of August 7, 2002
(as amended January 31, 2005 and February 5, 2007, the
“2002 Agreement”), pursuant to which AMS was to develop
certain products that BSC would then commercialize for sale and
pursuant to which AMS granted BSC an exclusive option to become the
distributor for a period of time of certain AMS products; and
WHEREAS, AMS and BSC entered into
that certain Product Development and Distribution Agreement as of
May 23, 2005 (the “2005 Agreement”) pursuant to
which AMS was to develop new applications of its brain-monitoring
technology in the area of the diagnosis and treatment of
neurological, psychiatric and pain disorders and BSC was appointed
the exclusive distributor of such products; and
WHEREAS, AMS and BSC entered into
that certain Letter Agreement dated August 7, 2002 (the
“Letter Agreement”), and that certain Security
Agreement dated August 7, 2002 (the “Security
Agreement”), pursuant to which BSC agreed to make revolving
interest-bearing loans (the “Revolving Loans”) to AMS
from time to time at the request of AMS, such revolving loans being
evidenced by that certain promissory note in the original principal
amount of $5,000,000 dated August 7, 2002 made by AMS in favor
of BSC (the “Revolving Note” and together with the
Letter Agreement and the Security Agreement, the “Credit
Agreements”); and
WHEREAS, AMS and BSC entered into
(a) that certain Stock Purchase Agreement dated as of
August 7, 2002 pursuant to which AMS sold and BSC purchased
1,428,572 shares (the “2002 Shares”) of AMS Common
Stock, $0.01 par value per share (the “Common Stock”)
and (b) that certain Stock Purchase Agreement dated as of
April 7, 2004 pursuant to which AMS sold and BSC purchased
500,000 shares of Common Stock (the “2004 Shares” and
together with the 2002 Shares, the “Initial Shares”);
and
WHEREAS, BSC holds of record as of
the date of this Agreement an aggregate of 6,013,239 shares (the
“Shares”) of Common Stock, including the Initial
Shares; and
WHEREAS BSC and AMS now intend to
terminate the 2002 Agreement, the 2005 Agreement and the Credit
Agreements and AMS will repurchase an aggregate of 2,000,000 Shares
immediately, consisting of the Initial Shares and an additional
71,428 Shares (collectively, the “Purchased Shares”)
and BSC will grant AMS an option to repurchase the remaining
Shares, all on the terms set forth herein.
NOW THEREFORE, the parties agree as
follows:
ARTICLE I
TERMINATION
1.1. TERMINATION OF 2002
AGREEMENT AND 2005 AGREEMENT. The 2002 Agreement and 2005
Agreement shall terminate effective immediately upon and subject to
completion of the delivery and payment contemplated on the Initial
Purchase Date pursuant to Section 2.1 hereof (the
“Termination Date”) and thereafter shall have no
further force or effect. Notwithstanding anything to the contrary
in either Section 10.3 of the 2002 Agreement or
Section 12.3 of the 2005 Agreement, all obligations under such
Agreements shall cease effective on the Termination Date, and on
such Termination Date all rights granted by either party under such
Agreements shall terminate (including, but not limited to, the
rights and obligations specified in Section 10.3 of the 2002
Agreement or Section 12.3 of the 2005 Agreement as surviving
termination) except that only Section 11.2 of the 2002
Agreement and Section 13.2 of the 2005 Agreement shall survive
the Termination Date.
1.2. TERMINATION OF CREDIT
AGREEMENTS. The Credit Agreements shall terminate effective
immediately upon and subject to the Termination Date and thereafter
shall have no further force or effect and on the Termination Date
the Revolving Note shall be deemed cancelled. In furtherance of the
foregoing, BSC agrees to execute such documents and instruments,
and also hereby authorizes AMS take such further actions and to
execute and file any such documents and instruments, as may be
reasonably required in order to effect the release of any lien or
security interest that may currently be in force with respect to
any Collateral (as defined in the Security Agreement) of AMS
pursuant to the Credit Agreements. BSC hereby agrees and
acknowledges that no Revolving Loan, or any interest or fees in
connection therewith, or any other indebtedness of AMS to BSC, is
currently outstanding.
ARTICLE II
PURCHASE OF
SHARES
2.1. SALE AND PURCHASE;
CONSIDERATION . On the terms and subject to the conditions
herein, AMS hereby agrees to purchase from BSC, and BSC hereby
agrees to sell to AMS, the Purchased Shares at a price per share
equal to the average closing price of the Common Stock as reported
on the Nasdaq Global Market for the twenty (20) consecutive
trading days up to and including the date of execution of this
Agreement (the “Initial Per Share Purchase
Price”).
2.2. DELIVERY AND PAYMENT.
Within two business days after the date of execution of this
Agreement (the “Initial Purchase Date”) (i) BSC
will deliver to AMS the certificate or certificates representing
the Purchased Shares, together with a stock power and assignment
duly executed in blank in the form attached hereto as
Exhibit A , and (ii) AMS will deliver to BSC an
amount equal to the product of (x) the Initial Per Share
Purchase Price multiplied by (y) the aggregate number of
Purchased Shares (the “Initial Purchase Price”), by
wire transfer of U.S. Dollars in immediately available funds.
- 2 -
2.3. REPRESENTATIONS AND
WARRANTIES OF BSC. As an inducement to AMS to enter into this
Agreement, BSC hereby represents and warrants to AMS that the
following statements are true, correct and complete in all material
respects as of the date hereof, and shall be true, correct and
complete in all material respects as of the Initial Purchase Date,
and as of each Call Option Purchase Date (except that on each Call
Option Purchase Date, the representations with respect to the
Shares shall mean the total number of Shares being purchased on
such date):
2.3.1 Requisite Power and Authority . BSC has all requisite
right, power and authority and full legal capacity to enter into
this Agreement, to carry out BSC’s obligations hereunder and
to consummate the transactions contemplated hereby. This Agreement
has been duly executed and delivered by BSC and, assuming due
authorization, execution and delivery by AMS, constitutes a valid
and binding obligation of BSC enforceable against BSC in accordance
with its terms.
2.3.2 Ownership of Shares . BSC is the lawful owner of the
Shares and has full right, title and interest in and to the Shares,
subject to no security interest, pledge, mortgage, lien, charge,
encumbrance, adverse claim, preemptive right, preferential
arrangement or restriction of any kind, including, without
limitation, any restriction on the use, voting, transfer (other
than restrictions under the Securities Act of 1933, as amended, and
state securities laws), receipt of income or other exercise of any
attributes of ownership that would impair BSC’s right or
ability to transfer the Shares to AMS.
2.3.3 Information. BSC has had the opportunity to discuss
with AMS’s officers and other directors the terms of the
transactions contemplated by this Agreement. BSC acknowledges that
by selling the Shares to AMS pursuant to this Agreement, BSC will
not benefit in any way from any future appreciation in the market
value of the Shares repurchased by AMS or any future sale of AMS or
any of its subsidiaries of any of their assets and businesses or
from any future distributions of cash or other property by AMS to
its shareholders.
2.3.4 Purchase Price. BSC agrees that the Initial Purchase
Price and the Option Purchase Price (as defined below) were
negotiated and determined between the parties following arm’s
length negotiations.
2.3.5 Consents . No consent, approval, order, or
authorization of, or registration, qualification, designation,
declaration, or filing of or with any governmental authority or
third party is required in conne
|